Sulforaphane Reduces the Chronic Inflammatory Immune Response of Human Dendritic Cells.

These findings demonstrate that SFN exerts protective effects against LPS-induced inflammation via the modulation of moDCs/T cells towards a regulatory profile. SFN may be a potential candidate for the treatment of pathologies with an inflammatory profile.